Aquilant is a leading provider of specialist healthcare and scientific products and services, providing outsourced sales, marketing, distribution and engineering for the medical and scientific sectors. Aquilant's promise to its customers is two-fold. For agency clients we promise that we will promote, distribute and manage their brands as if they were our own and we will do so as their partner, always adding value to what we do. For the healthcare professionals we work with, we promise that they will receive Aquilant's expert service and support to achieve the very best outcomes for their patients. As of the 25th of September 2018, the Competition & Consumer Protection Commission has approved the purchase by the Healthcare 21 Group of Aquilant Limited from H2 Equity Partners. The combination of Aquilant and HC21 represents a fabulous opportunity. The newly combined business now employs more than 450 staff across Ireland, UK, Germany and Austria. The scale of the expanded Healthcare21 Group and the experience and talent of our people will ensure significant growth and success for all involved. This is a fantastic opportunity for both Aquilant & Healthcare 21 and our combined experience, expertise and enthusiasm will ensure we reach our potential to be one of Europe’s leading healthcare distribution businesses.